3-hydroxypregn-4-en-20-one has been researched along with tetradecanoylphorbol acetate in 1 studies
| Studies (3-hydroxypregn-4-en-20-one) | Trials (3-hydroxypregn-4-en-20-one) | Recent Studies (post-2010) (3-hydroxypregn-4-en-20-one) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
|---|---|---|---|---|---|
| 29 | 0 | 2 | 31,050 | 61 | 2,217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, CA; Murphy, LD; Wiebe, JP; Wolfe, M | 1 |
1 other study(ies) available for 3-hydroxypregn-4-en-20-one and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Acute, nongenomic actions of the neuroactive gonadal steroid, 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP), on FSH release in perifused rat anterior pituitary cells.
Topics: 20-alpha-Dihydroprogesterone; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcimycin; Calcium Channel Agonists; Cells, Cultured; Estradiol; Female; Follicle Stimulating Hormone; GABA Modulators; Gonadotropin-Releasing Hormone; Ionophores; Perfusion; Pituitary Gland, Anterior; Pregnanolone; Progesterone; Rats; Rats, Sprague-Dawley; Serum Albumin; Tetradecanoylphorbol Acetate; Time Factors; Type C Phospholipases | 1997 |